Indivior PLC Ordinary Shares
Symbol: INDV (NASDAQ)
0.00
▼ (-100.00%) -24.150
Company Description:
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $24.15
- Yesterday High: $24.405
- Yesterday Low: $23.995
- Yesterday Volume: 968.63K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Indivior PLC Ordinary Shares
- Website: https://www.indivior.com
- Listed Date: 2014-12-24
- Location: SLOUGH, BERKSHIRE, X0
- Market Status: Active
- CIK Number: 0001625297
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.01B
- Round Lot: 100
- Outstanding Shares: 124.77M
- Asset Type: CS
RECENT FILINGS FOR INDV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 8-K | View |
| 2025-09-08 | 144 | View |
| 2025-09-08 | 144 | View |
| 2025-09-05 | SCHEDULE 13D/A | View |
| 2025-09-04 | 144 | View |
| 2025-08-28 | 144 | View |
| 2025-08-26 | 8-K | View |
| 2025-08-22 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-04 | 8-K/A | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-07-29 | SCHEDULE 13D/A | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-14 | SCHEDULE 13D/A | View |
| 2025-06-30 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-18 | SCHEDULE 13D/A | View |
| 2025-06-02 | 8-K | View |
| 2025-06-02 | 8-K | View |